journal article Mar 01, 2016

Leptomeningeal metastasis: Clinical experience of 519 cases

View at Publisher Save 10.1016/j.ejca.2015.12.021
Topics

No keywords indexed for this article. Browse by subject →

References
18
[1]
Chamberlain "Neoplastic meningitis" J Clin Oncol (2005) 10.1200/jco.2005.01.131
[2]
Chamberlain "Leptomeningeal metastasis" Curr Opin Oncol (2010) 10.1097/cco.0b013e32833de986
[3]
Groves "New strategies in the management of leptomeningeal metastases" Arch Neurol (2010) 10.1001/archneurol.2010.18
[4]
Freilich "Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis" Ann Neurol (1995) 10.1002/ana.410380111
[5]
Herrlinger "Leptomeningeal metastasis: survival and prognostic factors in 155 patients" J Neurol Sci (2004) 10.1016/j.jns.2004.05.008
[6]
Bruna "Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features" Cancer (2009) 10.1002/cncr.24041
[7]
Waki "Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors" J Neurooncol (2009) 10.1007/s11060-008-9758-3
[8]
Clarke "Leptomeningeal metastases in the MRI era" Neurology (2010) 10.1212/wnl.0b013e3181dc1a69
[9]
Palma "Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features" Clin Neurol Neurosurg (2013) 10.1016/j.clineuro.2012.03.048
[10]
Du "Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients" J Neurooncol (2013) 10.1007/s11060-013-1228-x
[11]
Passarin "Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge" Neurol Sci (2015) 10.1007/s10072-014-1881-7
[12]
Balm "Leptomeningeal carcinomatosis. Presenting features and prognostic factors" Arch Neurol (1996) 10.1001/archneur.1996.00550070064013
[13]
Wasserstrom "Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients" Cancer (1982) 10.1002/1097-0142(19820215)49:4<759::aid-cncr2820490427>3.0.co;2-7
[14]
Groves "Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor and stromal cell derived factor-1 levels in patients with neoplastic meningitis due to breast cancer, lung cancer and melanoma" J Neurooncol (2009) 10.1007/s11060-009-9819-2
[15]
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors

Lakshmi Nayak, Martin Fleisher, Rita Gonzalez-Espinoza et al.

Neurology 2013 10.1212/wnl.0b013e31828f183f
[16]
Jung "Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011" Cancer Res Treat (2014) 10.4143/crt.2014.46.2.109
[17]
Yi "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI" Lung Cancer (2009) 10.1016/j.lungcan.2008.10.016
[18]
Park "Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era" Lung Cancer (2012) 10.1016/j.lungcan.2011.11.022
Metrics
127
Citations
18
References
Details
Published
Mar 01, 2016
Vol/Issue
56
Pages
107-114
License
View
Cite This Article
Jae-Won Hyun, In Hye Jeong, AeRan Joung, et al. (2016). Leptomeningeal metastasis: Clinical experience of 519 cases. European Journal of Cancer, 56, 107-114. https://doi.org/10.1016/j.ejca.2015.12.021